Transformed mycosis fungoides: clinicopathological features and outcome
- 19 July 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 157 (2) , 284-289
- https://doi.org/10.1111/j.1365-2133.2007.08008.x
Abstract
Background Transformation of mycosis fungoides (T‐MF) occurs in 8–55% of MF patients. Its early histopathological diagnosis is of tremendous importance to better define the management and to establish the prognosis. Recent studies have demonstrated that advanced‐stage MF at diagnosis of transformation is the predominant risk factor of poor outcome. The 5‐year survival rates for stage IIB and IV MF are 26·9% and 10·6%, respectively. The prognostic value of the immunophenotypic characterization of the infiltrate has not been thoroughly studied in the literature. Objectives To retrieve clinical, histological and immunophenotypic features of T‐MF in our patient population and analyse their prognostic value. Patients and methods A register‐based retrospective study was performed including all patients with cutaneous T‐cell lymphoma (CTCL) registered in our two departments from January 2000 to December 2005. Among 208 patients with CTCL, 17 patients with proven transformation of their MF were studied. Clinical features and staging as well as immunophenotypic and pathological findings at the time of the initial diagnosis of MF and of the diagnosis of T‐MF were analysed. Results Our results, in accordance with previously published material, indicate that the main clinical prognostic factor in T‐MF is the stage of the initial disease at the time of the transformation. Patients with stage IIB–IV MF have a poor prognosis. In our study, strong expression of CD30 is linked to a better prognosis. Conclusions We believe that pathological and immunopathological documentation of progressive MF is important in order to identify T‐MF early; however, the differential diagnosis is sometimes difficult. Aside from already acknowledged prognostic factors such as older age, advanced initial disease and short delay to transformation, the CD30 immunophenotype could be regarded as a useful additional prognostic marker in T‐MF.Keywords
This publication has 11 references indexed in Scilit:
- Conjugal transformed mycosis fungoides: The unknown role of viral infection and environmental exposures in the development of cutaneous T-cell lymphomaJournal of the American Academy of Dermatology, 2006
- Classification of cutaneous T‐cell lymphoma: from Alibert to WHO‐EORTCJournal of Cutaneous Pathology, 2006
- Large cell transformation of mycosis fungoides: tetraploidization within skin tumor large cellsCancer Genetics and Cytogenetics, 2005
- Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and PrognosisBlood, 1998
- Histologic and Immunophenotypic Features Prior to Transformation in Patients with Transformed Cutaneous T-Cell LymphomaThe American Journal of Dermatopathology, 1998
- Clinicopathologic and Immunologic Features Associated With Transformation of Mycosis Fungoides to Large-Cell LymphomaThe American Journal of Surgical Pathology, 1992
- Clinical features associated with transformation of cerebriform T‐cell lymphoma to a large cell processHematological Oncology, 1990
- KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections.Journal of Clinical Pathology, 1989
- Granulomatous Variants of Cutaneous T-Cell LymphomaThe American Journal of Surgical Pathology, 1988
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981